Deferoxamine Mesylate for injection recall: Impurity Out of Spec
Deferoxamine Mesylate for injection, USP, Single-use Vial, 500 mg/vial, 10 mL vial. Intravenous, Intramuscular, Subcutaneous Use, Rx Only, Hospira…
Why was Deferoxamine Mesylate for injection recalled?
CGMP Deviations: Firm failed to control impurity for color change at the API stage.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot: 51275DD; Exp. 09/01/17
- Product
- Deferoxamine Mesylate for injection, USP, Single-use Vial, 500 mg/vial, 10 mL vial. Intravenous, Intramuscular, Subcutaneous Use, Rx Only, Hospira…
- Recalling firm
- Pfizer Inc.
- Quantity
- 32,276 10 mL vials
- Distribution
- Nationwide
- Recall date
- October 11, 2017
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)